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Available online 25 November 2011Abstract While damaged peripheral nerves demonstrate some potential to regenerate, complete functional recovery re-
mains infrequent, owing to a functional loss of supportive Schwann cells distal to the injury. An emerging solution to improve
upon this intrinsic regenerative capacity is to supplement injured nerves with stem cells derived from various tissues. While
many of these strategies have proven successful in animal models, few studies have examined the behavior of transplanted
stem cells in vivo, including whether they survive and differentiate. In previous work, we demonstrated that cells derived
from neonatal rodent dermis (skin-derived precursor cells, or SKPs) could improve regenerative parameters when transplanted
distal to both acute and chronic nerve injuries in Lewis rats. The aim of this work was to track the fate of these cells in various
nerve injury paradigms and determine the response of these cells to a known glial growth factor. Here, we report that SKPs
survive, respond to local cues, differentiate into myelinating Schwann cells, and avoid complete clearance by the host's im-
mune defenses for a minimum of 10 weeks. Moreover, the ultimate fate of SKPs in vivo depends on the nerve environment
into which they are injected and can be modified by inclusion of heregulin-1β.
© 2011 Elsevier B.V. All rights reserved.Introduction
Rationale for stem cells in peripheral nerve lesions
Stem cells have attracted considerable interest of late for their
potential applicability to nervous system injury and disease.
Lesions of the peripheral nervous system are frequent and de-
bilitating, and only the mildest of injuries are associated with
acceptable functional recovery (Humphreys et al., 2007;⁎ Corresponding author at: Hotchkiss Brain Institute, Department of
Clinical Neuroscience, University of Calgary, HMRB 109-3330 Hospital
Drive NW, Calgary, Alberta, Canada T2N4N1. Fax: +1 403 270 7878.
E-mail address: skwagg@ucalgary.ca (S.K. Walsh).
1873-5061/$ - see front matter © 2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.scr.2011.11.004Noble et al., 1998). The capacity of the denervated distal
nerve to support axonal regeneration depends on proliferating
SCs within the basal lamina tube (Bungner, 1891) which are es-
sential for guiding regenerating axons to their denervated tar-
gets (y Cajal, 1928). Over time of denervation, however,
Schwann cells become refractory to neurotrophins and neuregu-
lins, downregulate the required receptors, and ultimately fail in
their ability to interact with axons and other non-neuronal cells
(You et al., 1997; Li et al., 1997). Though transplantation of
Schwann cells (SCs) into nerve and spinal cord injuries is an ob-
vious and biologically effective strategy (Guenard et al., 1992;
Guest et al., 1997), it is made somewhat impractical due to
their limited expansion potential, lengthy culture times, and
morbidity associated with nerve harvest to obtain sufficient
numbers of transplantable cells. Several alternative sources of
cellular therapy have thus been examined, including bone
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mis. Many of these precursor cell strategies have demonstrated
utility in treating peripheral nerve lesions in experimental ani-
mals (for review, see Walsh and Midha, 2009). However, how
precursor cells might respond to and modify the nerve environ-
ment and thereby confer regenerative advantage is largely
unknown.
Skin-derived precursor cells
The skin dermis contains neural crest-related precursor cells
(skin-derived precursors, or “SKPs”) that can differentiate
into neural crest cell types in vitro when supplied with the
appropriate cues, including those with characteristics of pe-
ripheral neurons and SCs (Fernandes et al., 2004; Toma et
al., 2001, 2005). Specifically, when SKPs are cultured with
heregulin-1β (a known differentiation factor of neural crest
cells destined to become SCs), they take on an apparent SC
phenotype (“SKP-SCs”) and can be transplanted distal to in-
juries of rodent peripheral nerve injuries (McKenzie et al.,
2006; Walsh et al., 2009, 2010). In previous work, we uti-
lized SKP-SCs as a source of exogenous Schwann cells to
seed isogeneic acellular grafts bridging defects in rodent pe-
ripheral nerve. Regeneration of nerves treated with SKP-SCs
was significantly improved over diluent control, and compa-
rable to autograft (the current best available method for
nerve repair) (Walsh et al., 2009). We next delivered SKP-
SCs into the distal segment of a chronically denervated tibial
nerve and found that we could enhance the typically barren
distal nerve environment toward one that was more growth-
supportive (Walsh et al., 2010). While these in vivo data
strongly supported the use of SKP-SCs as a potential source
of autologous Schwann cells for peripheral nerve transplan-
tation, the fate of these cells in vivo and their long-term
contribution to the nerve environment has yet to be fully
elucidated. This knowledge will be of crucial interest as we
consider the clinical translation of cell therapy for human
nerve repair. Given the ability of SKPs to survive and differ-
entiate into SCs distal to nerve crush (McKenzie et al., 2006)
we hypothesized that they would retain this ability in all
nerve environments. However, as the environments vary
with respect to nerve components such as basal lamina and
host Schwann cells, survival might be expected to differ be-
tween cell differentiation states as well as nerve injury
paradigms.
Present study
In this study, we examined the survival and differentiation of
SKPs at different timepoints following transplantation into
intact nerve, acutely denervated nerve, and chronically de-
nervated nerve. We found that the ultimate fate of SKPs in
vivo depends on the nerve environment into which they are
injected. Though their survival tends to be poorer on aver-
age than differentiated SKP-SCs, naïve SKPs are instructed
by the microenvironment of the nerve to take on a SC pheno-
type. Moreover, while SKPs did migrate several millimeters
from the injection site, they did not demonstrate significant
levels of proliferation after 1 week in the nerve. It also ap-
pears that the differentiation state of SKP-SCs is such that
they are sensitive to exogenous growth factors: supplyingheregulin-1β at the time cell injection decreases the level
of apoptosis occurring immediately after cell transplant.
Given this knowledge regarding the behavior of SKPs in pe-
ripheral nerve tissue, we hope to be able to modify various
aspects of the cells' biology to improve their utility for
nerve transplantation.
Results
SKP phenotype in vitro
Within 1–2 weeks of culture in bFGF and EGF, SKP cells iso-
lated from dissociated skin samples formed floating spheres
(Fig. 1A), while cells with fibroblastic morphology attached
to the dish and could be discarded by selectively passaging
only the floating cell population. Culturing aliquots of disso-
ciated SKP spheres in heregulin-1β and forskolin-containing
media resulted in adherent monolayers of cells with a bipo-
lar morphology identical to that observed in nerve-derived
SC cultures (Morrissey et al., 1991) (Fig. 1B). The SC pheno-
type was further confirmed via positive immunostaining
for GFAP, S100β, ErbB3, and p75NGFR (Fig. 1C). Of note,
some cells in the impure culture without this morphology
did not express SC markers. Therefore we identified SKP-
SCs as those that a) demonstrated a bipolar, spindle
shape and b) expressed GFAP. The entire process of differ-
entiation and purification of SKP-SCs takes on average of
2 weeks. We used only purified SKP-SCs meeting those
characteristics in further experiments requiring differenti-
ated cells.
Survival and differentiation of SKPs within the in-
jured nerve environment
Naïve SKPs were transplanted distal to nerve transection and
followed by immunohistochemistry of frozen sections
obtained at the follow-up timepoints (2 and 8 weeks). La-
beled (YFP+) cells could be found existing as a tract within
the endoneurium at each timepoint and condition assessed.
They migrated 2–3 mm from the injection site and were dis-
tributed over roughly 20% of the cross sectional area of the
nerve. At the 2 week follow-up (Table 1), survival was higher
(~10.5%) when SKPs were injected into an acutely injured
nerve versus after chronic denervation (~5.8%). A two-way
ANOVA run on the data in Table 1 demonstrated that nerve
environment had a significant effect on survival data
(F(2,18)=5.60, pb0.05). Interestingly, the fewest number
of cells could be counted from the intact nerve, indicat-
ing clearance or lack of survival within this environment.
At the 8 week follow-up, the number of cells retained de-
creased in all groups, such that there was no more than
~4% long-term survival when transplanting naïve SKPs.
Naive SKPs differentiated into GFAP positive SCs in the
peripheral nerve environment. Though SKPs implanted
into chronically denervated nerves had low survival,
they remarkably demonstrated high levels of differentia-
tion into SCs (73.3% and 76.5% at 2 and 8 weeks,
respectively).
Since the chronically denervated nerve appeared to be
poorly supportive for SKP survival, we used this environment
to test whether survival could be improved by differentiating
Figure 1 In vitro phenotype of SKP-SCs. A: SKPs cultured in DMEM/F12 media supplemented with EGF and bFGF form spheroid
colonies within 1 week of culture initiation. Phase contrast microscopy, 200× original magnification; scale bar=50 μm. B: when dif-
ferentiated in forskolin and heregulin-1β, SKPs attach to the culture substrate and differentiate into a Schwann cell phenotype, forming
confluent cultures of aligned bipolar cells (SKP-SCs). Phase contrast microscopy, 100× original magnification; scale bar=50 μm. C: after
2 weeks of differentiation, impure cultures of SKP-SCs were re-plated and stained with various Schwann cell markers. Note that only the
bipolar, spindle shaped cells demonstrate robust and positive immunofluorescence in most cases, while other cell morphologies tend not
to demonstrate staining. Omission of primary antibody (no 1°) served as a staining control. Fluorescentmicrograph, originalmagnification
400×. Scale bar=20 μm.
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Table 1 Survival and differentiation of SKPs in various nerve environments.
Time of SKP injection, harvest Mean number YFP-positive cell bodies % Survival Proportion GFAP-labeled
Immediate, 2 weeks 31,440 10.48±2.9% c 33.42±3.22% b,c
Immediate, 8 weeks 12,190 4.06±0.59% 22.92±1.79% b,c
Chronic denervation, 2 weeks 17,300 5.83±0.71% 73.31±3.41% a
Chronic denervation, 8 weeks 11,640 3.92±0.72% 76.54±8.48% a,c
Uninjured, 2 weeks 9360 3.13±0.66% a 67.32±2.38% a
Uninjured, 8 weeks 8000 2.68±0.14% 44.2±1.89% a,b
Naïve GFP-labeled SKP spheres were dissociated and 300,000 cells were injected distal to a sciatic nerve transection injury in immuno-
suppressed Sv129 mice either immediately after injury or following 8 weeks of chronic denervation. Histological assessment of nerve
sections harvested 2 weeks post transplant demonstrated a survival percentage of 10.48% in the acutely injured nerve, whereas when
delivered into a chronically denervated nerve, the number of detected SKPs decreased to 5.8%. Of note, however, was that the proportion
of GFAP-differentiated SKP-SCs increased in the chronically denervated nerve which had lower numbers of cells overall. Survival was
poorest in uninjured nerves. Data represent mean±SEM of n=4/group.
a Significantly different from immediate injection group at the equivalent timepoint.
b Significantly different from chronic denervation group at the equivalent timepoint.
c Significantly different from uninjured group at the equivalent timepoint (one-way ANOVA with post-hoc Tukey's multiple comparison test).
229Fate of stem cells in peripheral nerveSKPs into SCs prior to injection (Fig. 2). When SKP-SCs were
implanted into chronically denervated nerve, survival was
greater than that of naïve SKPs (6.0% versus 3.8%; pb0.05,
Student's t test).Proliferation and apoptosis of SKPs in vivo
SKPs maintained a basal low level of proliferation in vivo
over various time-points assessed. BrdU positive profiles
formed a low percentage of total labeled SKPs (4.2% at
1 week, 4.5% at 2 weeks and 3.6% at 3 weeks), and there
was no evidence of tumorigenesis throughout all experi-
ments with either SKPs or SKP-SCs, as demonstrated by
both gross and microscopic examination of transplanted
tissues.Figure 2 Survival of naive versus SC-differentiated SKPs in the
chronically denervated nerve. GFP-labeled naive or forskolin/
Hrg-1β-differentiated SKPs were injected at a concentration of
100,000 cells/ul distal to a sciatic nerve transection injury in
Sv129 mice following 8 weeks of chronic denervation, followed
by histological assessment of surviving YFP+ cells within the distal
nerve. After 2 weeks, 7.1% of differentiated cells versus 5.8% of
undifferentiated cells were found to survive. This difference
was significantly different at 8 weeks with 6% survival in differ-
entiated cells and 3.8% survival in undifferentiated cells.
*pb0.05 (two-tailed Student's t test).Because survival was particularly poor in cells trans-
planted into intact nerves versus transected nerves, we
asked whether they were being cleared by apoptosis early
after transplantation. We repeated the injection techniques
described above, and transplanted DiI-labeled naïve SKPs
into either an intact rat nerve or one that had been transected
immediately prior to cell delivery, and quantified caspase 3
positive SKPs in representative sample sections. At 24 h,
36.9% of the SKPs counted from the intact nerve were under-
going apoptosis. Distal to transection injury, 23.05% of the
cells transplanted were apoptotic (Fig. 3). This difference
was not statistically significant.
Maintenance of SC fate in peripheral nerve
We next wanted to assess whether differentiated SKP-SCs
remained in the injured nerve and retained their phenotype
over the longer term, or whether they were subject to en-
gulfment by macrophages secondary to a prolonged inflam-
matory response. When Lewis rat SKP-SCs, pre-labeled in
vitro with lipophilic DiI, were implanted within a isogeneic
acellular graft, they retained a SC phenotype for at least
10 weeks (Fig. 4A). In this environment, 38% of all counted
cells were S100β/DiI positive, i.e. SKP-SCs. However, 20%
of the counted cells were DiI positive only (accounting for
34% of total DiI positive cells), indicating a population of
cells that had either de-differentiated or expanded from
contaminating cells in the original injection. While there
were ED-1 positive macrophages in the grafts at this time-
point, few appeared to double-label with SKPs (11%), demon-
strating minimal ongoing immune response (Fig. 4B). More-
over, there appeared to be a spatial separation between the
column of transplanted SKPs and the infiltratingmacrophages,
withmacrophages tending to favor the extremities of the graft
and the SKPs forming a continuous cord in the center of the
graft.
Finally, SKP-SCs show the capacity to produce myelin
both in vitro (Fig. 5A) and in vivo. The SKP-SCs retained with-
in the nerve took on a myelinating phenotype once axonal
contact was re-established, as they enveloped regenerating
axons and expressed myelin proteins.
Figure 3 Apoptosis of SKPs following transplantation into the nerve. SKPs were either transplanted into the intact sciatic nerve or
distal to transection injury (n=4/group). Nerves were harvested at 24 h, at which point the number of caspase 3 positive (apoptotic)
SKP cells in the sampled area was quantified. A: a mean of 36.90±4.2% of SKP cells were caspase positive in the intact nerve, while
23.05 4.8% of SKPs were caspase positive distal to transection. Data represent mean±SEM; pN0.05 by two-tailed Student's t test.
B: fluorescent micrograph demonstrating nuclear caspase 3 staining (green) of SKP-SCs (red). Nuclei are labeled with Hoescht.
Arrow: caspase 3 positive SKP-SC. Asterisk: caspase 3 positive, non-SKP cell. 400× original magnification.
230 S.K. Walsh et al.Effect of neuregulins on limiting SKP apoptosis
Finally, we asked whether neuregulins may be an important
director of SKP fate. It appeared that in vitro, SKP-SCs were
sensitive to heregulin-1β, as removal of this component from
the culture media resulted in an approximate doubling of ap-
optosis in these cells (Fig. 6A; pb0.001, Student's t test). We
then found that early apoptosis of SKPs in nerve tissue could
be minimized by application of exogenous heregulin-1β con-
comitantly with cell injection (Fig. 6B). In each animal, cells
in the presence of heregulin-1β were injected into the sciat-
ic nerve of the right leg, and those in DMEM alone were
injected into the left leg. The treatment with 500 ng/ml
heregulin-1β resulted in significantly fewer apoptotic SKPs
after 24 h (pb0.01, Student's t test).
Discussion
Major findings
The major findings of this study were: (1) skin-derived pre-
cursor cells (SKPs) demonstrate variable survival and capac-
ity for differentiation within peripheral nerves, dependingon the nerve injury environment, (2) Schwann cell prediffer-
entiation of SKPs improves their survival in nerve lesions and
(3) SKP-SCs retain their SC fate over time and myelinate
regenerating axons, forming a permanent component of
the regenerated nerve. Finally (4), SKPs are sensitive to
neuregulins, and injecting them concomitantly with
heregulin-1β significantly decreases the level of apoptosis
occurring in these cells upon transplantation into nerve
tissueTracking survival of stem cell transplants
Recently, investigators have placed greater emphasis on the
retention and differentiation of stem cells transplanted into
the nervous system. However, is long term survival of most
of the transplanted cells an absolute requirement for their
therapeutic activity? Some investigators have noted recov-
ery from various lesions with few remaining stem cells and
in the absence of their overt differentiation, suggesting al-
ternative mechanisms of support, such as enhancing host re-
pair mechanisms (Prockop, 2007; Marcus et al., 2008). In this
study, we saw roughly 10% survival at 2 weeks, meaning that
at minimum, 90% of the cells are lost before full functional
Figure 4 Long term fate of SKP-SCs within an acellular graft bridging a rodent sciatic nerve lesion. A: SKP-SCs retain their S100β+pheno-
type for at least 10 weeks following transplantation into acellular nerve grafts. Red = DiI labeled cells, green = S100β staining, yellow= double
labeled cells. A′: immunofluorescent quantification of randomly selected fields of sectioned grafted areas determined that, of the cells
counted, 20% were DiI positive only (SKPs), 40% were DiI and S100β positive (SKP-SCs), and 40% were S100β+ only (host SCs). B: SKP-SCs
avoid long-term immune engulfment by resident macrophages within the acellular graft. Confocal image, red = DiI labeled cells, green =
ED-1 staining, yellow = double labeled cells. B′: immunofluorescent quantification of graft sections demonstrated that 27% of counted
cells were DiI+ only, 11% were DiI and ED-1+ (SKPs engulfed by macrophages), and 61% were ED-1+ only. A, B: 100× original magnification;
scale bar=100 μm. “C”: center graft; “P”: periphery of graft.
231Fate of stem cells in peripheral nerverecovery is expected to take place. While we have shown
that the cells undergo apoptosis fairly early, there may be
other reasons to explain absence of cells within the nerve.
For this reason, it is particularly important for investigators




Figure 5 SKP-SCs demonstrate a myelinating phenotype in vitro.
neurites (far red) and express myelin basic protein (555). All nuclei vis
ment of SKP-SCs along neurites (pseudocolored as gray for presentatioof cells through the needle does not cause them damage,
and dissociate cells adequately into single cell suspension
prior to injection. These errors were minimized in these ex-
periments by checking viability before and after passage
through the needle, and by incorporating Fast Green dye inMerge 
GFP lentivirus transduced neonatal SKP-SCs (GFP) envelop DRG
ualized with Hoescht (blue). Merge demonstrating intimate align-
n purposes).
Figure 6 SKP-SCs myelinate regenerating axons in vivo. A–C: spectral confocal image of several myelin figures, labeled for MBP
(blue, Alexa 405). A: the MBP co-localizes with DiI fluorescence (red) of SKP-SC produced myelin. B: spectral unmix of DiI fluorescence
from the dashed-line box of the previous figure (pseudocolor green). C: spetral unmix of Alexa 405 fluorescence (MBP, psueodocolor
red) of the same area above. D–F: highmagnification cross-section view of a single axon fromadifferent staining preparation, demonstrating
myelination by a SKP cell. SKP-SCs were pre-labeled with DiI (D), and axons were stained with alexa 405 for neurofilament (E). F: merge
of blue and red signals. G: intensity versus wavelength graph demonstrating two distinct and specific emission peaks for myelin and SKP
cells. *: Alexa 405 (MBP), **: DiI (SKPs), as detected from the solid box area of A).
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endoneurial target. Of note, the ideal number of cells for
transplant in peripheral nerve injuries has not been thor-
oughly investigated, with numbers as few as 4×103 cells
and as many as 2×107 cells reported in the literature (Hu
et al., 2007; Aquino et al., 2006). We chose 3–5×105 cells
for our study as this was an intermediate value comparable
to that used in previous studies employing SKPs (McKenzie
et al., 2006). These survival data imply that further studies
must be undertaken to determine a) if this is in fact enough
cells to maximize any therapeutic benefit they may have,
and b) whether cell survival and long term retention can be
improved somehow. Moreover, the results highlight the
need for careful consideration and refinement of cell deliv-
ery techniques for therapeutic use.One of the main requirements of any study involving stem
cells is a reliable method to track the transplanted cells over
the long term. Here, we have employed two techniques: de-
riving cultures from fluorescent transgenic animals and ex-
posing cultured cells to the lipophilic carbocyanine
derivative CM-DiI. Though the use of fluorescent cells de-
rived from transgenic animals is an ideal method to ensure
homogenous staining, label retention, and cell viability, it
necessitated immunosuppression of the recipient animals.
Immunosuppression with cyclosporine A, aside from being
nephrotoxic, also has variable effects on nerve regeneration
itself (Meirer et al., 2002). In order to work with a somewhat
better-characterized model of nerve regeneration and avoid
immunosuppression, we switched to inbred Lewis rats for
both the cell source and recipient animals. These isogenous
Figure 7 Heregulin-1β modifies the fate of SKPs. A: growth of newly-differentiated SKP-SCs for 48 h in media containing 10 ng/ml
heregulin-1β resulted in significantly less apoptosis than growth in complete culture media lacking this factor, as assessed by
immunocytochemistry for apoptotic marker cleaved caspase 3. B: inclusion of heregulin into SKPs' diluent prior to injecting
into peripheral nerves significantly decreases number of apoptotic SKPs seen at 24 h. Data represent mean±SEM; **pb0.01,
***pb0.001, Student's t test.
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of dilution or loss of signal for at least 10 weeks following
transplantation. Following a standard 20 min staining proce-
dure, roughly 95% of cells are stained, with no evidence of
cell damage which can occur with other labeling methods.
These dyes have the advantage of being technically simple
to use, rapid, and resistant to leakage to nearby cells
(Nishiura et al., 2004). Our laboratory has also had recent
success using lentiviral techniques to introduce fluorescent
proteins for robust labeling of stem cells prior to transplant
or in vitro use.Importance of differentiation state
Very few studies compare survival and efficacy of naive ver-
sus pre-differentiated cells within a lesion site, despite the
fact that each should be considered a separate cell type
with different survival requirements. In this study, SKP-SCs
showed significantly better survival in the chronically dener-
vated nerve than naïve SKPs. Mature Schwann cells are
known to survive in the absence of axons by establishment
of an autocrine signaling loop, whereas those taken from
embryonic nerves rely on axonal cues for survival (Meier
et al., 1999). It may be that immature precursor cells such
as the naive SKPs do not possess the appropriate signaling
mechanisms to survive in the chronically denervated envi-
ronment, which is essentially devoid of viable axons. This is
corroborated by the finding that, of those originally naive
SKPs that did survive, many had differentiated into GFAP
positive SCs, perhaps conferring them with this autocrine
survival strategy (Table 1). Thus, to be considered a practi-
cal strategy, care should be taken with respect to the differ-
entiation state of the cells: either transplant more naive
cells in expectation of their loss, or transplant cells in a
pre-differentiated state. Another argument for transplant-
ing cells that are differentiated towards the cell typeneeded in the environment is the assumption that they
would exhibit more of the desirable traits of the native SCs
and fewer less desirable traits commonly associated with
undifferentiated stem cells, such as tumor formation or allo-
dynia (Hofstetter et al., 2005; Amariglio et al., 2009). For
example, in a model of spinal cord injury, SKP-SCs outper-
formed naïve SKPs with respect to remyelination, neural
protection, and reducing reactive gliosis (Biernaskie et al.,
2007). For this reason, and because of the survival data pre-
sented here, we chose to use differentiated SKP-SCs for our
studies of nerve regeneration (Walsh et al., 2009,
2010).While we did not assess the phenotype of SKPs not dif-
ferentiating into SCs, the aforementioned study found that
they might differentiate into smooth muscle or adipocytes
(Biernaskie et al., 2007).Wemust therefore carefully consider
the impact that such inappropriate differentiation would have
on the regenerating nerve and the success of SKP-based
therapies.
Of upmost importance is the function of these cells in the
nerve environment, specifically their ability to myelinate
regenerating axons, which is paramount to the appropriate
functioning of grafted SCs from any source. In this study,
the SKP-SCs retained within the nerve indeed took on a mye-
linating phenotype (Fig. 6). In previous work, Mckenzie et al.
used immunoelectron microscopy to demonstrate that SKPs
produced compact myelin in a Shiverer mouse model
(McKenzie et al., 2006). We are currently undertaking exper-
iments using confocal and electron microscopy to determine
what percentage of retained SKPs may be generating bona-
fide myelin, and what the functional and electrophysiological
implications of this myelin may be in the regenerated nerve.Influence of nerve environment
Given the ability of naive SKPs to differentiate in vivo, it ap-
pears that the microenvironment of the injured nerve is
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ries, neurons convert from a “transmitting” mode to a
“growth” mode (Fenrich and Gordon, 2004), during which
they express genes associated with growth cone elongation
as well as those that mediate their interaction with sur-
rounding Schwann cells. These include growth factor recep-
tors, cell adhesion molecules, and neuregulins (Fu and
Gordon, 1997). Other candidates include the cytokines and
growth factors produced by cells in the nerve microenviron-
ment, such as FGF, TGFβ, and PDGF (Chandross et al., 1995;
Reynolds and Woolf, 1993).
That SKPs demonstrated poorest survival in the intact
nerve was very interesting, and corroborates findings of
other groups studying stem cellular supplementation of ner-
vous system injuries (Han et al., 2004; Liu et al., 2000;
Franklin et al., 1996). Though the mechanism for such exclu-
sion is not entirely known, Franklin and colleagues have sug-
gested that stem cells transplanted into the intact spinal
cord are perhaps considered supernumerary and are cleared
by apoptosis in a recapitulation of developmental events. In-
deed, in our studies cells were shown to be undergoing a
very high degree of apoptosis within 24 h after transplanta-
tion, which supports this hypothesis.Effect of exogenous neuregulins
One of the most interesting findings of this work was that the
fate of transplanted stem cells is exquisitely sensitive to the
environment in which they are placed with respect to their
retention, differentiation, and death. Therefore, in addition
to the common practice of enhancing stem cells' supportive
phenotype, considerations regarding requirements for sur-
vival in a particular environment must also be made. Pan
and colleagues found that administration of G-CSF to ani-
mals receiving transplants of amniotic fluid mesenchymal
stem cells not only improved survival of transplanted cells
but also augmented nerve regeneration over that of a pri-
marily cell-based approach (Pan et al., 2008). Here, we
attempted to utilize a similar strategy to improve retention
of SKPs within the peripheral nerve. Recent evidence from
Biernaskie et al. (2007) and our laboratory has suggested
that SKP-SCs are similar to Schwann cell precursors (SCPs)
with respect to their secretion of trophic factors and activity
within the environments of injured peripheral nerve and spi-
nal cord. SCPs are the main glial cell within the rodent pe-
ripheral nervous system at E14. The period between E14/
15 and E17/18 is critical in nerve development, since during
this period SCPs mature into Schwann cells, an event that is
identified by a loss of reliance on axonal support and neure-
gulins for survival (Dong et al., 1995; Grinspan et al., 1996).
Indeed, removal of heregulin-1β from the cell culture media
of SKP-SCs resulted in a significant increase in apoptosis
(Fig. 7A). We wondered if this loss of trophic support might
explain the considerable amount of apoptosis that occurs in
SKPs 24 h after their transplantation (particularly in the in-
tact nerve, where neuregulins are minimal). We found that
addition of heregulin-1β significantly decreased the number
of apoptotic SKPs at 24 h. However, what is not known from
these data is whether preventing early apoptosis will trans-
late to larger numbers of cells retained over the long term
and also whether this will positively impact subsequentnerve regeneration. We are currently exploring these ques-
tions in our laboratory.
Impact of transplanted cells on nerve environment
Finally, just as the SKP cell's phenotype is affected by the mi-
croenvironment, these cells are also likely modifying their mi-
lieu. We showed previously that SKP-SCs secrete various
neurotrophic factors capable of inducing neurite outgrowth
in vitro (Walsh et al., 2009). While a certain proportion of
SKP-SCs injected into peripheral nerve lesions can be
expected to interact directly with regenerating axons, prelim-
inary evidence has suggested that they are acting in an indi-
rect manner as well, especially since the survival indices of
SKP-SCs in chronically injured nerves are only in the order of
around 6% (Fig. 2). Studies transplanting SKP-SCs into the in-
jured spinal cord resulted in a significant increase in the re-
cruitment of host Schwann cells into the cord relative to
neural stem cells types or diluent alone (Biernaskie et al.,
2007). Although the mechanism of such recruitment is un-
known, this suggests that at least part of their contribution
to repair may involve enhancing endogenous repair mecha-
nisms via host Schwann cell recruitment to the site of injury.
Current studies are underway to determine if this is the case
in the peripheral nerve as well. Additionally, SKP-SCs have
been shown in the model of spinal cord injury to modify their
local environment within the glial scar by reducing expression
of inhibitory extracellular matrix components such as neuro-
can (Biernaskie et al., 2007). It is possible that SKP-SCs exhibit
similar effects in the chronically denervated nerve, also
thought to be inhibitory to axon elongation (Heine et al.,
2004). Our laboratory is currently exploring the incorporation
of extracellular matrix degradation capability within SKP-SC
therapies to further improve regeneration through chronically
denervated nerves.
Conclusion
The findings of this study outline the need for greater con-
sideration of cell fate following transplantation into the ner-
vous system. By further understanding cell attributes in vivo
such as survival, proliferation, death and differentiation, in-
vestigators can manipulate the relevant variables with the
expectation of enhancing their utility in nerve regeneration.
Methods
Cell culture and characterization
For initial survival experiments in the mouse model, skin-
derived precursor cells (SKPs) were generated from dermis
of postnatal day 2 transgenic YFP-expressing mice [(Jax
lab; Stock: Tg(GFPU)5Nagy/J)] and cultured according to
published protocols (Toma et al., 2001; Biernaskie et al.,
2006). For subsequent experiments where a rat model was
used, cells were obtained from postnatal day 2 Lewis rats
(Charles River, QC). Regardless of cell source, cultures
were handled identically. Briefly, pups were quickly decapi-
tated and skin on the dorsal torso was sterilized with a 70%
EtOH swab prior to removal with sterile scissors. Collected
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[GIBCO, Burlington ON]) on ice and then incubated for ap-
proximately 45 min in 0.1% collagenase at 37 °C. Skin pieces
were mechanically dissociated, washed in cold DMEM and
passed through a 40 μm cell strainer. Filtrate was centri-
fuged at 1200 rpm and the pellet was triturated and resus-
pended to a concentration of 50,000 cells/ml in culture
media (DMEM-F12 [GIBCO] 3:1, 1% penicillin/streptomycin
[Sigma, Oakville ON]) containing B-27, 20 ng/ml EGF and
40 ng/ml bFGF (all from Gibco-BRL). Cells were cultured
and passaged three times as undifferentiated spheres in
25 cm2 tissue culture flasks (Corning, Corning NY) in a
37 °C, 5% CO2 tissue-culture incubator. To induce differenti-
ation towards Schwann cells, spheres were triturated and
replated on poly-D lysine/laminin coated culture dishes
(Corning) in DMEM/F12 media with 4 μM forksolin, 10 ng/ml
heregulin-1β, and 1% N2 supplement (Gibco). After incuba-
tion for 1 week, cells appearing under phase contrast to
have bipolar SC morphology (confirmed with glial fibrillary
acidic protein (GFAP) staining of sister cultures) were isolat-
ed with cloning cylinders and expanded in the same medium
until N95% purity was achieved. Schwann cells were
obtained from sciatic nerve of the same P2 neonates used
for SKP generation as previously described (Walsh et al.,
2009).
Immunocytochemistry
Cultured SKP-SCs were fixed in ice-cold absolute methanol for
20 min and blocked with goat serum for 1 h. Cells were then
probed with rabbit anti-GFAP (1:200; Sigma), rabbit anti-
S100β (1:100, Santa Cruz), rabbit anti-ErbB3 (1:200, Santa
Cruz) and rabbit anti-p75 NGFR (1:200, Santa Cruz), and visu-
alized with anti-rabbit 488 or anti-rabbit 555 (Molecular
Probes, Inc, Burlington, ON). Nuclei were labeled with
Hoescht 33342 (1:5000, Invitrogen, Burlington, ON). Visualiza-
tion was carried out under a fluorescence microscope (Olym-
pus BX51, Center Valley, PA)
In vitro myelination
Dorsal root ganglia (DRGs) from P10 rat pups were grown in
Lab Tek chamber slides (Nunc, Rochester NY) with nerve
growth factor (NGF; 50 ng/ml) and 2.5% FBS in neurobasal
media with antibiotics. After 2 days, 7 μg/ml cytosine arabi-
noside was given for 96 h to eliminate endogenous Schwann
cells. After day 6 GFP lentivirus-transduced SKP-SCs
(150,000 cells/well) were seeded on DRGs. SKP-SCs were
allowed to associate with axons for 5 days followed by induc-
tion of myelination with 50 μg/ml ascorbic acid. After
14 days, DRG/SKP-SC cocultures were fixed and stained for
myelin (MBP, 1:200; visualized with 555) axons (TUJ1,
1:1000, Santa Cruz; visualized with far red) and nuclei
(Hoechst 1:500).
Animals
Behavior of SKPs in peripheral nerve injury was first investi-
gated in a mouse model in order to correlate with the origi-
nal data published by McKenzie et al. (2006). For these
experiments, pharmacologically immunosuppressed (as de-
scribed below) adult male Sv129 mice (Jackson Laboratories,
Bar Harbor ME) were used. We used a Lewis rat model for allsubsequent experiments because finer surgical repair tech-
niques required larger nerves, and the ability to use an in-
bred strain and isologous transplants eliminated the need
for immunosuppression. Animals were maintained in a tem-
perature and humidity controlled environment with a 12 h
light/dark cycle. Food (Purina, Mississauga, ON) and water
were available ad libitum. Surgical interventions were car-
ried out under inhalation anesthetic (Isofluroane, 99.9% Hal-
ocarbon Laboratories, River Edge, NJ) and pain control was
provided by means of intraperitoneal or oral administration
of buprinorphene. Surgical procedures were carried out
aseptically, and standard microsurgical techniques were
used with an operating microscope (Wild M651; Wild Leitz,
Willowdale, ON). Animals were sacrificed at endpoint
under deep anesthesia using an overdose of intracardiac
Euthanol (Bimeda-MTC, Cambridge, ON). The protocol was
approved and monitored by the University of Calgary animal
care committee and adhered strictly to guidelines set by the
Canadian Council on Animal Care.Survival and differentiation of SKPs in nerve injury
Sv129 mice immunosuppressed with cyclosporin A (20 mg/kg/
day) served as recipients of SKPs or SKPs-SCs from YFP+ mice
for these experiments (Midha et al., 1994). Immunosuppres-
sion was required in this case as the donor animals were
from an outbred stock. The sciatic nerve was exposed in the
proximal thigh and transected or left intact. In the first exper-
iment, 3 μl of naïve SKP cells (100,000 cells/μl) were injected
deep to the epineurium of the nerve using a 30 gauge needle
fitted to a Hamilton syringe either immediately or following
8 weeks of chronic denervation. Chronic denervation was
established by cutting the sciatic nerve in the proximal thigh
and capping both the distal and proximal stumps with
silicone-occluded silastic tubing to prevent reinnervation.
The second experiment also employed the chronic denerva-
tion paradigm, however animals were given either naïve
SKPs or differentiated SKP-SCs in order to compare their sur-
vival. In all experiments, the transected nerve was left un-
repaired in order to assess viability of SKPs independently
from ingrowing axons and Schwann cells. Cell viability of
SKPs prior to and after injections was verified to be N90% by
Trypan blue dye exclusion in each experiment from an aliquot
from the same suspension. To determine SKP survival in the
absence of ingrowing axons and proximal Schwann cells,
nerves were left unrepaired for the duration of the study.
Animals (n=4/group/time-point) were sacrificed at 24 h,
2 weeks or 8 weeks post-transplant and the distal nerve
was collected for immunohistochemistry and morphometry.
A subset of animals received intraperitoneal injections of
BrdU (5-bromo-2′-deoxyuridine, Sigma) at 100 mg/kg 4 h
before harvesting at 1 week in order to assess proliferation
of transplanted cells (Chen et al., 2005). Isolated segments
were fixed whole in 4% paraformaldehyde overnight, cryo-
protected in 20% sucrose, embedded in O.C.T compound
(VWR, Mississauga, ON) and then longitudinally sectioned
at 16 μm with a cryostat (Leica Microsystems Inc, Richmond
Hill ON) at −22 °C and mounted on Superfrost slides (Fisher
Scientific). Sections were blocked with 1% BSA and incubat-
ed overnight in primary antibody (rabbit anti-GFAP, 1:500;
Sigma, mouse anti-BrdU, 1:200; Abd Serotec, Oxford, UK,
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1:100; Cell Signaling Technology, Boston MA). Myelination
by SKP-SCs was confirmed by staining axons with neurofila-
ment (1:400) and Myelin Basic Potein (MBP 1:200) both
from Santa Cruz. Following a wash with PBS, slides were in-
cubated with secondary antibody (anti rabbit or anti mouse
405, 555 or 488; 1:400; Molecular Probes) for 2 h. Slides were
then washed and coverslipped using Fluorosave reagent (Cal-
biochem, San Diego, CA) and viewed under a fluorescence mi-
croscope (Olympus BX51, Center Valley, PA). Omission of
primary or secondary antibody was used as negative control
for the staining process. SKPs (YFP+ or YFP/GFAP+) were
counted in every eighth section and counts were multiplied
by 8 to adjust for sampling frequency (McKenzie et al.,
2006) in order to assess survival and quantify non-
differentiated cells and SC-differentiated cells within each
environment presented. Myelin was visualized using the
fluorescent hydrophobic probe Nile red (Arnaud et al.,
2009).
Maintenance of SC phenotype in acellular grafts
In order to assess long-term maintenance of the SC pheno-
type of SKP-SCs used in acellular graft repair and assess
their overall contribution to SC count in the nerve, we car-
ried out an experimental paradigm analogous to what we
have previously reported (Walsh et al., 2009). We created
a 12 mm gap in the sciatic nerve of Lewis rats, and subse-
quently repaired it with an isogenic graft rendered acellular
by repeated freezing and thawing (Ide et al., 1983; Hall,
1986). At this time, 3 μl of DiI (Invitrogen) labeled rat SKP-
SCs were injected into both the distal and proximal 3 mm
of the acellular grafts, giving a total of 5×105 cells delivered
in 6 μl of media. Controls consisted of isografts receiving
media alone or autograft repair (the current gold standard
of treatment). At 10 weeks post-transplant, nerves were
harvested for immunohistochemistry as described above,
and every section throughout the thickness of nerve was col-
lected. Primary antibodies used were rabbit anti-S100β
(1:100; Santa Cruz), and mouse anti-macrophage/monocyte
clone ED-1 (1:200; Chemicon, Billerica, MA). Secondary anti-
bodies were anti-rabbit or anti-mouse 488 (1:400; Molecular
Probes, Inc). Sections were viewedwith a confocal microscope
(Zeiss Scanning system, LSM 510) in order to assess co-
localization of fluorescence signals. Three random high-
powered fields/section were photographed, taking 3 sections
throughout the thickness of the nerve (9 images/nerve) in
order to assess phenotype of injected SKP-SCs. Identical im-
ages were obtained in each channel and then merged to iden-
tify DiI signal only (SKPs), DiI+488 signals (SKPs+macrophage
or SKP-SC), or 488 signal only (host SC or host macrophage).
An observer blinded to treatment groups used this method to
compare the number of SCs in SKP-SC treated grafts, media
treated grafts and autografts, and the counts expressed are
based on a sampling area of 12,000 μm2.
Regulation of SKPs' early apoptosis by heregulin-1β
From the experiments above, we noted that SKPs showed
poorest survival in the intact nerve and the chronically de-
nervated nerve—two environments that are potentiallydevoid of accessible neuregulins. Moreover, a considerable
amount of apoptosis in transplanted cells likely occurs within
24 h, likely due to the fact that cultured cells lose both their
in vitro attachment and trophic factors when dissociated and
placed in vivo. We first tested the reliance of SKP-SCs on
neuregulins in vitro by growing newly-differentiated SKP-
SCs in the presence or absence of heregulin-1β for 48 h.
Cells were plated at equal density in each chamber of two
4-well Chamber Slides (Nunc, Rochester NY). Half of the
wells received heregulin-1β (10 ng/ml) and the other half
received its diluent (PBS). After 48 h, cells were fixed in
methanol and processed for immunocytochemistry as de-
scribed above. Apoptotic cells were labeled with anti-
cleaved caspase 3 (1:250) (detected with anti-rabbit 488).
Percentage of SKPs undergoing apoptosis was counted from
three random fields of view per well (at 1000× magnifica-
tion) by an observer blinded to the treatment.
We next sought to determine whether inclusion of
heregulin-1β into the injection cocktail could decrease apo-
ptosis observed at 24 h. For this experiment, surgeries to ex-
pose the nerve of adult Lewis rats were performed
bilaterally, as described above. 300,000 DiI labeled SKP-SCs
(suspended in DMEM with or without 500 ng/μl heregulin-
1β) were injected distal to the injury site. Twenty four
hours later, nerves were harvested and processed for immu-
nohistochemistry, labeling with cleaved caspase 3 (1:100)
and detected with anti-rabbit 488. The analysis method de-
scribed above for percentage differentiated cells was used
to quantify caspase positive cells in this experiment. Fluo-
rescence microscopy was employed, using the appropriate
filters to detect DiI labeled cells (SKP-SCs) and 488 signal
(caspase 3 labeled, apoptotic cells). Images were merged
using ImageJ (NIH) in order to quantify the percentage of ap-
optotic SKP-SCs.
Statistical analysis
Differences between differentiated versus naïve cell survival
and apoptosis with or without heregulin were compared
using a two-tailed Student's t-test. A two-way ANOVA was per-
formed to detect whether there was an effect of nerve envi-
ronment on survival. Statistical significance was accepted at
pb0.05, with all results presented as the mean±SEM.
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